A Dose Escalating Study of HC002 in Healthy Adult Volunteers

NCT06670274 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Disease
Autoimmune Diseases

Interventions

DRUG: HC002 SAD
DRUG: HC002 MAD
DRUG: Placebo

Sponsor

Holoclara Aus Pty Ltd